Identifying predictors of weight loss and metabolic health after bariatric surgery
Official title: Preoperative Predictors of Weight Loss and Improved Metabolic Health After Bariatric Surgery
Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT05987631 · Data updated 2026-11-12
This study is trying to find out what factors can help predict how well people with insulin resistance will lose weight and improve their health after having bariatric surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Academic / other |
| Locations | 3 sites (Gouda, South Holland and 2 other locations) |
| Status | Recruiting |
| Started | January 19, 2023 |
| Main results expected | August 31, 2024 |
| Study ends | August 31, 2027 |
| Registry record updated | August 14, 2023 |
| Trial ID | NCT05987631 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 75 with a BMI of 40 kg/m2 or higher, or 35 kg/m2 with obesity-related comorbidities, who are scheduled for primary bariatric procedures.
✕Probably not a fit
Patients with medical conditions unrelated to obesity or those with poorly managed hypothyroidism may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify preoperative predictors that influence weight loss and metabolic health improvements following bariatric surgery. The research focuses on various factors including inflammation, insulin sensitivity, psychological traits, feeding behaviors, and cardiorespiratory fitness. By understanding these predictors, the study seeks to tailor treatment approaches for individuals undergoing bariatric surgery, thereby optimizing their outcomes. The study will involve patients scheduled for Roux-en-Y gastric bypass or Sleeve Gastrectomy, with a focus on those who are insulin resistant.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for patients undergoing bariatric surgery.
How similar studies have gone: Other studies have shown success in identifying predictors of outcomes after bariatric surgery, making this approach both relevant and promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ability to provide informed consent * Patient is ≥ 18 and ≤ 75 years old * BMI ≥ 40 kg/m2 or ≥ 35 kg/m2 with obesity related comorbidity * Scheduled for primary bariatric procedure: Roux-en-Y gastric bypass (RYGB) or Sleeve Gastrectomy (SG) * Stable weight 3 months prior to inclusion weight (\<10% change in body weight for 3 months prior to assessments) In order to be eligible to participate in the subgroup of this study, we will use the following inclusion criteria: * Ability to provide informed consent * Patient is ≥ 18 and ≤ 75 years old * BMI ≥ 40 kg/m2 or ≥ 35 kg/m2 with obesity related comorbidity * Patients scheduled for RYGB * Patients who are insulin resistant (impaired fasting glucose (\> 5.6 mmol/L) or fasting insulin \> 74 pmol/L) * Postmenopausal women (to prevent bias due to the effect of sex hormones on insulin sensitivity) Exclusion Criteria: * Any actual medical condition except for obesity related health issues or well treated hypothyroidism * Pregnancy anticipated in the first two years following surgery A potential subject who meet the following criteria will be excluded from participation in the subgroup of this study: * Coagulation disorders and/or use anticoagulants * Use of any medication except for statins, antihypertensives (except for Angiotensine converting enzyme (ACE)- or angiotensin receptor blockers) and thyroid hormone * Diabetes mellitus type 2
Where it's running
-
Nederlandse Obesitas Kliniek Den Haag
The Hague, South Holland, Netherlands Recruiting -
Nederlandse Obesitas Kliniek Gouda
Gouda, South Holland, Netherlands Not yet recruiting -
Nederlandse Obesitas Kliniek Nieuwegein
Nieuwegein, Utrecht, Netherlands Not yet recruiting
Study contacts
- Principal investigator: Mireille JM Serlie, Prof. Dr. — Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Study coordinator: Rieneke van der Meer, Drs.
- Email: r.vandermeer1@amsterdamumc.nl
- Phone: +31703204703
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding genetic factors that affect weight loss after bariatric surgery
This study is trying to find out if certain genes can help predict how well people with severe obesity will lose weight after having bariatric surgery.
-
Understanding why some patients don't lose weight after bariatric surgery
This study is trying to find out why some people don’t lose as much weight as expected after bariatric surgery, focusing on the role of gut hormones to help improve their results.
-
Survey on bariatric surgery for adolescents
This study is trying to see how well laparoscopic adjustable gastric banding works for teenagers aged 14-20 who are having bariatric surgery, focusing on weight loss and any health issues that might come up.
-
Registry for bariatric surgery quality control
This study is setting up a registry to track the results and safety of bariatric surgery for people who are severely obese to help improve surgical practices.
-
Long-term follow-up of severely obese patients after bariatric surgery
This study is trying to see how well different types of weight loss surgery work for severely obese patients over the long term and how it affects their health and quality of life.
-
Glycemic variability after SASI versus Roux-en-Y gastric bypass
This trial tests whether SASI or Roux-en-Y gastric bypass leads to different glucose fluctuations in adults with severe obesity using continuous glucose monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.